Utility and Safety of Intrathecal Methotrexate Treatment in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis: A Pilot Study

Utility and Safety of Intrathecal Methotrexate Treatment in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis: A Pilot Study

Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a treatable autoimmune neurologic syndrome that occurs with or without tumor association. However, some severe cases are refractory to systemic immunotherapy. This pilot study aimed to evaluate the utility and safety of intr...

Full description

Bibliographic Details
Main Authors: Xun-Zhe Yang, Hua-Dong Zhu, Hai-Tao Ren, Yi-Cheng Zhu, Bin Peng, Li-Ying Cui, Hong-Zhi Guan
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Anti-N-methyl-D-aspartate Receptor Encephalitis; Injections; Methotrexate
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=2;spage=156;epage=160;aulast=Yang

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=2;spage=156;epage=160;aulast=Yang

Similar Items